AMERICAN INTERNATIONAL GROUP, INC. - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,295,708
+28.3%
25,617
+18.5%
0.01%
+33.3%
Q2 2023$1,009,625
+56.8%
21,624
+28.5%
0.01%
+50.0%
Q1 2023$643,725
-28.8%
16,825
+2.0%
0.00%
-33.3%
Q4 2022$903,707
+99.5%
16,491
+24.0%
0.01%
+100.0%
Q3 2022$453,000
+265.3%
13,298
+1.4%
0.00%
+200.0%
Q2 2022$124,000
-31.5%
13,110
+2.7%
0.00%0.0%
Q1 2022$181,000
-37.4%
12,765
-6.6%
0.00%0.0%
Q4 2021$289,000
-8.3%
13,663
-2.9%
0.00%
-50.0%
Q3 2021$315,000
-11.8%
14,072
-2.3%
0.00%
+100.0%
Q2 2021$357,000
+55.9%
14,406
+82.6%
0.00%0.0%
Q1 2021$229,000
+12.8%
7,891
+0.3%
0.00%0.0%
Q4 2020$203,000
-18.5%
7,870
-2.8%
0.00%0.0%
Q3 2020$249,000
+46.5%
8,096
+18.3%
0.00%0.0%
Q2 2020$170,000
+61.9%
6,841
+38.0%
0.00%0.0%
Q1 2020$105,000
+54.4%
4,956
+61.9%
0.00%
Q4 2019$68,000
-1.4%
3,062
+1.5%
0.00%
Q3 2019$69,0003,0180.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders